Publicaties
2023
Wetenschappelijke publicaties
Bondue, T., Berlingerio, S. P., Siegerist, F., Sendino-Garví, E., Schindler, M., Cairoli, S., Goffredo, B. M., Arcolino, F. O., Dieker, J., Janssen, M., Endlich, N., Brock, R., Gijsbers, R., Heuvel, L. V. D., & Levtchenko, E. (2023). CTNSmRNA as a potential treatment for nephropathic cystinosis. bioRxiv. https://doi.org/10.1101/2023.04.28.538106
Yang, Y., Mihajlovic, M., Janssen, M. J., & Masereeuw, R. (2023). The Uremic Toxin Indoxyl Sulfate Accelerates Senescence in Kidney Proximal Tubule Cells. Toxins, 15(4), 1-18. [242]. https://doi.org/10.3390/toxins15040242
2022
Wetenschappelijke publicaties
Genderen, A. M. V., G Valverde, M., Capendale, P. E., Kersten, V., Sendino Garví, E., Schuurmans, C. C. L., Ruelas, M., Soeiro, J. T., Tang, G., Janssen, M. J., Jansen, J., Mihăilă, S. M., Vermonden, T., Zhang, Y. S., & Masereeuw, R. (2022). Co-axial Printing of Convoluted Proximal Tubule for Kidney Disease Modeling. Biofabrication, 14(4), 1-16. [044102]. https://doi.org/10.1088/1758-5090/ac7895
García Valverde, M., Ferreira Faria, J., Sendino Garví, E., Janssen, M. J., Masereeuw, R., & Mihaila, S. (2022). Organs-on-chip technology: a tool to tackle genetic kidney diseases. Pediatric Nephrology, 37(12), 2985-2996. https://doi.org/10.1007/s00467-022-05508-2
Garví, E. S., Masereeuw, R., & Janssen, M. J. (2022). Bioengineered Cystinotic Kidney Tubules Recapitulate a Nephropathic Phenotype. Cells, 11(1), 1-18. [177]. https://doi.org/10.3390/cells11010177
2021
Wetenschappelijke publicaties
Taranta, A., elmonem, M. A., Bellomo, F., Leo, E. D., Boenzi, S., Janssen, M. J., Jamalpoor, A., Cairoli, S., Pastore, A., Stefanis, C. D., Colucci, M., Rega, L. R., giovannoni, I., Francalanci, P., Heuvel, L. P. V. D., Dionisi-Vici, C., Goffredo, B. M., Masereeuw, R., Levtchenko, E., & Emma, F. (2021). Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis. Cells, 10(12), 1-16. [3294]. https://doi.org/10.3390/cells10123294
Jamalpoor, A., van Gelder, C. A. G. H., Yousef Yengej, F. A., Zaal, E. A., Berlingerio, S. P., Veys, K. R., Pou Casellas, C., Voskuil, K., Essa, K., Ammerlaan, C. M. E., Rega, L. R., van der Welle, R. E. N., Lilien, M. R., Rookmaaker, M. B., Clevers, H., Klumperman, J., Levtchenko, E., Berkers, C. R., Verhaar, M. C., ... Janssen, M. J. (2021). Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis. EMBO Molecular Medicine, 13(7), 1-20. [e13067]. https://doi.org/10.15252/emmm.202013067
Jamalpoor, A., Othman, A., Levtchenko, E. N., Masereeuw, R., & Janssen, M. J. (2021). Molecular Mechanisms and Treatment Options of Nephropathic Cystinosis. Trends in Molecular Medicine, 27(7), 673-686. https://doi.org/10.1016/j.molmed.2021.04.004
Rood, J. J. M., Jamalpoor, A., van Hoppe, S., van Haren, M. J., Wasmann, R. E., Janssen, M. J., Schinkel, A. H., Masereeuw, R., Beijnen, J. H., & Sparidans, R. W. (2021). Extrahepatic metabolism of ibrutinib. Investigational New Drugs, 39(1), 1-14. https://doi.org/10.1007/s10637-020-00970-x
2020
Wetenschappelijke publicaties
Jamalpoor, A., van Gelder, C. A. G. H., Yousef Yengej, F. A., Zaal, E. A., Berlingerio, S. P., Veys, K. R., Pou Casellas, C., Voskuil, K., Essa, K., Ammerlaan, C., Rega, L. R., van der Welle, R., Lilien, M. R., Rookmaaker, M. B., Clevers, H. C., Klumperman, J., Levtchenko, E., Berkers, C. R., Verhaar, M. C., ... Janssen, M. J. (2020). Cysteamine-bicalutamide combination treatment restores alpha-ketoglutarate and corrects proximal tubule phenotype in cystinosis. (pp. 1-53). bioRxiv. https://doi.org/10.1101/2020.02.10.941799
De Leo, E., Elmonem, M. A., Berlingerio, S. P., Berquez, M., Festa, B. P., Raso, R., Bellomo, F., Starborg, T., Janssen, M. J., Abbaszadeh, Z., Cairoli, S., Goffredo, B. M., Masereeuw, R., Devuyst, O., Lowe, M., Levtchenko, E., Luciani, A., Emma, F., & Rega, L. R. (2020). Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis. Journal of the American Society of Nephrology : JASN, 31(7), 1522-1537. https://doi.org/10.1681/ASN.2019090956
Sun, Y., Goes Martini, A., Janssen, M. J., Garrelds, I. M., Masereeuw, R., Lu, X., & Danser, A. H. J. (2020). Megalin: A Novel Endocytic Receptor for Prorenin and Renin. Hypertension (Dallas, Tex. : 1979), 75(5), 1242-1250. https://doi.org/10.1161/HYPERTENSIONAHA.120.14845
2019
Wetenschappelijke publicaties
Abyar, S., Khandar, A. A., Salehi, R., Abolfazl Hosseini-Yazdi, S., Alizadeh, E., Mahkam, M., Jamalpoor, A., White, J. M., Shojaei, M., Aizpurua-Olaizola, O., Masereeuw, R., & Janssen, M. J. (2019). In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes. Scientific Reports, 9, [14686]. https://doi.org/10.1038/s41598-019-51109-9
Janssen, M. J., Nieskens, T. T. G., Steevels, T. A. M., Caetano-Pinto, P., den Braanker, D., Mulder, M., Ponstein, Y., Jones, S., Masereeuw, R., den Besten, C., & Wilmer, M. J. (2019). Therapy with 2'-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption. Molecular Therapy - Nucleic Acids, 18, 298-307. https://doi.org/10.1016/j.omtn.2019.08.025
Mihajlovic, M., Hariri, S., Westphal, K. C. G., Janssen, M. J., Oost, M. J., Bongiovanni, L., Van Den Heuvel, L. P., De Bruin, A., Hilbrands, L. B., & Masereeuw, R. (2019). Safety evaluation of conditionally immortalized cells for renal replacement therapy. Oncotarget, 10(51), 5332-5348. https://doi.org/10.18632/oncotarget.27152
2018
Wetenschappelijke publicaties
Jamalpoor, A., Sparidans, R. W., Casellas, C. P., Rood, J. J. M., Joshi, M., Masereeuw, R., & Janssen, M. J. (2018). Quantification of cystine in human renal proximal tubule cells using liquid chromatography-tandem mass spectrometry. Biomedical Chromatography, 32(8), 1-7. [e4238]. https://doi.org/10.1002/bmc.4238
2017
Wetenschappelijke publicaties
Mihajlovic, M., Fedecostante, M., Oost, M. J., Steenhuis, S. K. P., Lentjes, E. G. W. M., Maitimu-Smeele, I., Janssen, M. J., Hilbrands, L. B., & Masereeuw, R. (2017). Role of Vitamin D in Maintaining Renal Epithelial Barrier Function in Uremic Conditions. International Journal of Molecular Sciences, 18(12), [2531]. https://doi.org/10.3390/ijms18122531
2016
Wetenschappelijke publicaties
Janssen, M. J., Arcolino, F. O., Schoor, P., Kok, R. J., & Mastrobattista, E. (2016). Gene based therapies for kidney regeneration. European Journal of Pharmacology, 790, 99-108. https://doi.org/10.1016/j.ejphar.2016.07.037
Janssen, M. J., & Masereeuw, R. (2016). An introduction to the pharmacology of kidney regeneration. European Journal of Pharmacology, 790, 1-2. https://doi.org/10.1016/j.ejphar.2016.06.055
Caetano-Pinto, P., Janssen, M. J., Gijzen, L., Verscheijden, L., Wilmer, M. J. G., & Masereeuw, R. (2016). Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line. Molecular Pharmaceutics, 13, 933-944. https://doi.org/10.1021/acs.molpharmaceut.5b00821
2015
Wetenschappelijke publicaties
Janssen, M. J., Salomon, J., Cnossen, W. R., Bergmann, C., Pfundt, R., & Drenth, J. P. H. (2015). Somatic loss of polycystic disease genes contributes to the formation of isolated and polycystic liver cysts. Gut, 64(4), 688-90. https://doi.org/10.1136/gutjnl-2014-308062
2012
Wetenschappelijke publicaties
Janssen, M. J., & Drenth, J. P. H. (2012). Reply. Gastroenterology, 142(3), e27. https://doi.org/10.1053/j.gastro.2012.01.025
Janssen, M. J., Salomon, J., Te Morsche, R. H. M., & Drenth, J. P. H. (2012). Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. PLoS One, 7(11), e50324. https://doi.org/10.1371/journal.pone.0050324
2011
Wetenschappelijke publicaties
Waanders, E., Janssen, M. J., & Drenth, J. P. H. (2011). Response to Palmirotta et al. The frequency of the PRKCSH GAG trinucleotide repeat in PCLD patients. Clinical Genetics, 79(4), 399-400. https://doi.org/10.1111/j.1399-0004.2010.01537.x
Janssen, M. J., Woudenberg, J., Te Morsche, R. H. M., & Drenth, J. P. H. (2011). Loss of heterozygosity in liver cysts of autosomal dominant polycystic liver disease (PCLD) depends on germline mutation of the patient. 279. https://doi.org/10.1016/S0168-8278(11)60698-3
Janssen, M. J., Waanders, E., Te Morsche, R. H. M., Xing, R., Dijkman, H. B. P. M., Woudenberg, J., & Drenth, J. P. H. (2011). Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease. Gastroenterology, 141(6), 2056-2063.e2. https://doi.org/10.1053/j.gastro.2011.08.004
2010
Wetenschappelijke publicaties
Janssen, M. J., Waanders, E., Woudenberg, J., Lefeber, D. J., & Drenth, J. P. H. (2010). Congenital disorders of glycosylation in hepatology: the example of polycystic liver disease. Journal of Hepatology, 52(3), 432-440. https://doi.org/10.1016/j.jhep.2009.12.011